Endo International (NASDAQ: ENDP)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.440 | 0.660 | 0.2200 | ||||
REV | 633.410M | 652.259M | 18.849M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Endo International (NASDAQ: ENDP) through any online brokerage.
Other companies in Endo International’s space includes: Opiant Pharma (NASDAQ:OPNT), WAVE Life Sciences (NASDAQ:WVE), Satsuma Pharmaceuticals (NASDAQ:STSA), Lipocine (NASDAQ:LPCN) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Endo International (NASDAQ: ENDP) was reported by BMO Capital on Monday, May 9, 2022. The analyst firm set a price target for 2.00 expecting ENDP to rise to within 12 months (a possible 452.49% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Endo International (NASDAQ: ENDP) is $0.362 last updated May 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Endo International.
Endo International’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Endo International.
Endo International is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.